scholarly article | Q13442814 |
P356 | DOI | 10.1080/13547500902783739 |
P8608 | Fatcat ID | release_qdrhemftazbv3jr7ae4ggg45ca |
P932 | PMC publication ID | 4415987 |
P698 | PubMed publication ID | 19330584 |
P50 | author | Philippe Grandjean | Q16145198 |
Teresa Coccini | Q53127233 | ||
P2093 | author name string | Pal Weihe | |
Luigi Manzo | |||
Ulrike Steuerwald | |||
Frodi Debes | |||
P2860 | cites work | In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents | Q23917153 |
Umbilical cord mercury concentration as biomarker of prenatal exposure to methylmercury | Q24813643 | ||
Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia | Q28244485 | ||
The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical | Q28270262 | ||
Association between the CHRM2 gene and intelligence in a sample of 304 Dutch families | Q28271932 | ||
Developmental neurotoxicity of industrial chemicals | Q28279457 | ||
Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B | Q28366805 | ||
Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats | Q48336459 | ||
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition | Q48430459 | ||
Methylmercury interaction with lymphocyte cholinergic muscarinic receptors in developing rats. | Q48483350 | ||
Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury | Q48492467 | ||
Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Que., Canada | Q48640626 | ||
Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain | Q48894311 | ||
Pathological gambling and platelet MAO activity: a psychobiological study. | Q51046522 | ||
Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology. | Q51977326 | ||
Cognitive development in preschool children prenatally exposed to PCBs and MeHg. | Q52020776 | ||
Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. | Q52068277 | ||
Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders? | Q52098285 | ||
Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder. | Q53572234 | ||
Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. | Q53920138 | ||
Muscarinic Acetylcholine Receptors on Human Lymphocytes in Patients with Meniere's Disease | Q58272674 | ||
Platelet monoamine oxidase activity in obsessive-compulsive disorder | Q60366398 | ||
Changes of muscarinic cholinergic binding by lymphocytes in parkinson's disease with and without dementia | Q67856020 | ||
Effect of PCB and DES on rat monoamine oxidase, acetylcholinesterase, testosterone, and estradiol ontogeny | Q68100195 | ||
Decreased platelet monoamine oxidase activity in female bulimia nervosa | Q73521205 | ||
Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder | Q74599885 | ||
Brain monoaminergic neurotransmission parameters in weanling rats after perinatal exposure to methylmercury and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) | Q28567869 | ||
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models | Q29547388 | ||
Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury | Q29615556 | ||
Neurodevelopmental toxicity of methylmercury: Laboratory animal data and their contribution to human risk assessment | Q31155504 | ||
Assessing effects of neurotoxic pollutants by biochemical markers | Q31848578 | ||
Attention and executive deficits in Alzheimer's disease. A critical review | Q33545617 | ||
Human platelet monoamine oxidase activity in health and disease: a review | Q33848742 | ||
Maternal seafood diet, methylmercury exposure, and neonatal neurologic function | Q33901206 | ||
Association of CHRM2 with IQ: converging evidence for a gene influencing intelligence | Q34589759 | ||
Neonatal exposure to 3,3',4,4'-tetrachlorobiphenyl: changes in spontaneous behaviour and cholinergic muscarinic receptors in the adult mouse | Q34956636 | ||
A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury | Q35056196 | ||
Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring | Q35134674 | ||
Monoamine oxidase-B inhibition in Alzheimer's disease | Q35617449 | ||
Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning? | Q35853203 | ||
Neurobehavioural and molecular changes induced by methylmercury exposure during development | Q36797999 | ||
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development | Q36925551 | ||
Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiers | Q37119494 | ||
Platelet monoamine oxidase B activity in workers exposed to styrene | Q38532677 | ||
Vulnerable periods and processes during central nervous system development | Q40632179 | ||
Biochemical markers of neurotoxicity. A review of mechanistic studies and applications | Q41178207 | ||
Teratogen update: polychlorinated biphenyls | Q41568830 | ||
Lymphocyte muscarinic receptors and platelet monoamine oxidase-B as biomarkers of CNS function: effects of age and gender in healthy humans | Q42491975 | ||
Platelet serotonin concentrations in medicated schizophrenic patients | Q42507013 | ||
Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction? | Q43813971 | ||
Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice. | Q43833022 | ||
Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements | Q44096219 | ||
Platelet MAO in subtypes of alcoholism | Q44123428 | ||
Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender. | Q44203714 | ||
The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression. | Q44638219 | ||
Decreased (3H) quinuclidinyl benzilate binding to lymphocytes in Gilles de la Tourette syndrome. | Q46018390 | ||
Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlates | Q46078104 | ||
An interspecies comparison of mercury inhibition on muscarinic acetylcholine receptor binding in the cerebral cortex and cerebellum | Q46483179 | ||
Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions | Q46502417 | ||
Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men. | Q46549768 | ||
Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicants | Q46697263 | ||
Effects of developmental co-exposure to methylmercury and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) on cholinergic muscarinic receptors in rat brain | Q46925087 | ||
Effects of prenatal methylmercury exposure on brain monoamine oxidase activity and neurobehaviour of rats | Q46953943 | ||
Chronic L-deprenyl or L-amphetamine: equal cognitive enhancement, unequal MAO inhibition | Q47634252 | ||
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes | Q48099696 | ||
Perinatal co-exposure to methylmercury and PCB153 or PCB126 in rats alters the cerebral cholinergic muscarinic receptors at weaning and puberty. | Q48111814 | ||
Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years | Q48148022 | ||
Monoamine oxidases: activities, genotypes and the shaping of behaviour | Q48208271 | ||
Disruption by methylmercury of membrane excitability and synaptic transmission of CA1 neurons in hippocampal slices of the rat. | Q48269671 | ||
Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase | Q48295329 | ||
P433 | issue | 2 | |
P921 | main subject | Faroe Islands | Q4628 |
polychlorinated biphenyl | Q211171 | ||
biomarker | Q864574 | ||
P304 | page(s) | 67-76 | |
P577 | publication date | 2009-03-01 | |
P1433 | published in | Biomarkers | Q4915076 |
P1476 | title | No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls | |
P478 | volume | 14 |
Q28397719 | Application of Neurochemical Markers for Assessing Health Effects after Developmental Methylmercury and PCB Coexposure |
Q23916607 | Metrological assessment of a portable analyzer for monitoring the particle size distribution of ultrafine particles |
Q46492710 | Platelet oxygen consumption as a peripheral blood marker of brain energetics in a mouse model of severe neurotoxicity |
Q38092557 | Systematic analysis of the relationship between standardized prenatal exposure to polychlorinated biphenyls and mental and motor development during follow-up of nine children cohorts |
Search more.